Christian Wider1, Owen A Ross, Zbigniew K Wszolek. 1. Division of Neurology, Department of Clinical Neuroscience, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. christian.wider@chuv.ch
Abstract
PURPOSE OF REVIEW: Elucidating the genetic background of Parkinson disease and essential tremor is crucial to understand the pathogenesis and improve diagnostic and therapeutic strategies. RECENT FINDINGS: A number of approaches have been applied including familial and association studies, and studies of gene expression profiles to identify genes involved in susceptibility to Parkinson disease. These studies have nominated a number of candidate Parkinson disease genes and novel loci including Omi/HtrA2, GIGYF2, FGF20, PDXK, EIF4G1 and PARK16. A recent notable finding has been the confirmation for the role of heterozygous mutations in glucocerebrosidase (GBA) as risk factors for Parkinson disease. Finally, association studies have nominated genetic variation in the leucine-rich repeat and Ig containing 1 gene (LINGO1) as a risk for both Parkinson disease and essential tremor, providing the first genetic evidence of a link between the two conditions. SUMMARY: Although undoubtedly genes remain to be identified, considerable progress has been achieved in the understanding of the genetic basis of Parkinson disease. This same effort is now required for essential tremor. The use of next-generation high-throughput sequencing and genotyping technologies will help pave the way for future insight leading to advances in diagnosis, prevention and cure.
PURPOSE OF REVIEW: Elucidating the genetic background of Parkinson disease and essential tremor is crucial to understand the pathogenesis and improve diagnostic and therapeutic strategies. RECENT FINDINGS: A number of approaches have been applied including familial and association studies, and studies of gene expression profiles to identify genes involved in susceptibility to Parkinson disease. These studies have nominated a number of candidate Parkinson disease genes and novel loci including Omi/HtrA2, GIGYF2, FGF20, PDXK, EIF4G1 and PARK16. A recent notable finding has been the confirmation for the role of heterozygous mutations in glucocerebrosidase (GBA) as risk factors for Parkinson disease. Finally, association studies have nominated genetic variation in the leucine-rich repeat and Ig containing 1 gene (LINGO1) as a risk for both Parkinson disease and essential tremor, providing the first genetic evidence of a link between the two conditions. SUMMARY: Although undoubtedly genes remain to be identified, considerable progress has been achieved in the understanding of the genetic basis of Parkinson disease. This same effort is now required for essential tremor. The use of next-generation high-throughput sequencing and genotyping technologies will help pave the way for future insight leading to advances in diagnosis, prevention and cure.
Authors: Mary M Hulihan; Lianna Ishihara-Paul; Jennifer Kachergus; Liling Warren; Rim Amouri; Ramu Elango; Rab K Prinjha; Ruchi Upmanyu; Mounir Kefi; Mourad Zouari; Samia Ben Sassi; Samia Ben Yahmed; Ghada El Euch-Fayeche; Paul M Matthews; Lefkos T Middleton; Rachel A Gibson; Fayçal Hentati; Matthew J Farrer Journal: Lancet Neurol Date: 2008-06-06 Impact factor: 44.182
Authors: Owen A Ross; Alexandra I Soto; Carles Vilariño-Güell; Michael G Heckman; Nancy N Diehl; Mary M Hulihan; Jan O Aasly; Sigrid Sando; J Mark Gibson; Timothy Lynch; Anna Krygowska-Wajs; Grzegorz Opala; Maria Barcikowska; Krzysztof Czyzewski; Ryan J Uitti; Zbigniew K Wszolek; Matthew J Farrer Journal: Parkinsonism Relat Disord Date: 2008-09-14 Impact factor: 4.891
Authors: Daniel G Healy; Mario Falchi; Sean S O'Sullivan; Vincenzo Bonifati; Alexandra Durr; Susan Bressman; Alexis Brice; Jan Aasly; Cyrus P Zabetian; Stefano Goldwurm; Joaquim J Ferreira; Eduardo Tolosa; Denise M Kay; Christine Klein; David R Williams; Connie Marras; Anthony E Lang; Zbigniew K Wszolek; Jose Berciano; Anthony H V Schapira; Timothy Lynch; Kailash P Bhatia; Thomas Gasser; Andrew J Lees; Nicholas W Wood Journal: Lancet Neurol Date: 2008-06-06 Impact factor: 44.182
Authors: Z Gan-Or; N Giladi; U Rozovski; C Shifrin; S Rosner; T Gurevich; A Bar-Shira; A Orr-Urtreger Journal: Neurology Date: 2008-04-23 Impact factor: 9.910
Authors: Nathan Pankratz; Jemma B Wilk; Jeanne C Latourelle; Anita L DeStefano; Cheryl Halter; Elizabeth W Pugh; Kimberly F Doheny; James F Gusella; William C Nichols; Tatiana Foroud; Richard H Myers Journal: Hum Genet Date: 2008-11-06 Impact factor: 4.132
Authors: Dennis P Wall; Rimma Pivovarov; Mark Tong; Jae-Yoon Jung; Vincent A Fusaro; Todd F DeLuca; Peter J Tonellato Journal: BMC Med Genomics Date: 2010-10-29 Impact factor: 3.063
Authors: Pedro Gonzalez-Alegre; Jorge Di Paola; Kai Wang; Shay Fabbro; Hung-Chun Yu; Tamim H Shaikh; Benjamin W Darbro; Alexander G Bassuk Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2014-10-20
Authors: Olga Momcilovic; Renuka Sivapatham; Tal Ronnen Oron; Morten Meyer; Sean Mooney; Mahendra S Rao; Xianmin Zeng Journal: PLoS One Date: 2016-05-18 Impact factor: 3.240
Authors: Andreas Puschmann; Fabienne C Fiesel; Thomas R Caulfield; Roman Hudec; Maya Ando; Dominika Truban; Xu Hou; Kotaro Ogaki; Michael G Heckman; Elle D James; Maria Swanberg; Itzia Jimenez-Ferrer; Oskar Hansson; Grzegorz Opala; Joanna Siuda; Magdalena Boczarska-Jedynak; Andrzej Friedman; Dariusz Koziorowski; Monika Rudzińska-Bar; Jan O Aasly; Timothy Lynch; George D Mellick; Megha Mohan; Peter A Silburn; Yanosh Sanotsky; Carles Vilariño-Güell; Matthew J Farrer; Li Chen; Valina L Dawson; Ted M Dawson; Zbigniew K Wszolek; Owen A Ross; Wolfdieter Springer Journal: Brain Date: 2016-11-02 Impact factor: 15.255